10x Genomics, Inc. TXG Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s cash ratio?
- 10x Genomics, Inc. (TXG) reported cash ratio of 4.3× in Q1 2026.
- How has 10x Genomics, Inc.'s cash ratio changed year-over-year?
- 10x Genomics, Inc.'s cash ratio increased by 23.5% year-over-year, from 3.5× to 4.3×.
- What is the long-term trend for 10x Genomics, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s cash ratio has grown at a -11.9% compound annual growth rate (CAGR), from 5.8× to 3.1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.